|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 16/22 | (2006.01) |
| C07K 16/28 | (2006.01) | ||
| C12N 15/13 | (2006.01) | ||
| C12N 15/85 | (2006.01) |
| (11) | Number of the document | 1838733 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05854387.7 |
| Date of filing the European patent application | 2005-12-19 | |
| (97) | Date of publication of the European application | 2007-10-03 |
| (45) | Date of publication and mention of the grant of the patent | 2011-08-24 |
| (46) | Date of publication of the claims translation | 2011-12-27 |
| (86) | Number | PCT/US2005/045657 |
| Date | 2005-12-19 |
| (87) | Number | WO 2006/068953 |
| Date | 2006-06-29 |
| (30) | Number | Date | Country code |
| 638354 P | 2004-12-21 | US | |
| 711289 P | 2005-08-25 | US |
| (72) |
GREEN, Larry L., US
ZHOU, Qing, US
KEYT, Bruce, A., US
YANG, Xiao-dong, US
EMERY, Stephen Charles, GB
BLAKEY, David C., GB
|
| (73) |
Medimmune Limited,
Milstein Building Granta Park, Cambridge, Cambridgeshire CB21 6GH,
GB
|
| (74) |
Liucija JANICKAITĖ,
Inpatra UAB, Šeškinės g. 59-53, LT-07162 Vilnius,
LT
|
| (54) | Prieš angiopoetiną-2 nukreiptas antikūnas ir jo panaudojimai |
| ANTIBODIES DIRECTED TO ANGIOPOIETIN-2 AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2015-06-19 | 10 | 346.50 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2015-12-19 |